[The principles in correcting secondary immunodeficiencies by using 2 immunomodulators of differing character--purified staphylococcal anatoxin and likopid].
Semenova
I B
IB
Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001428:Bacterial Vaccines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000276:immunology; D013208:Staphylococcal Toxoid / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D013208:Staphylococcal Toxoid; D014765:Viral Vaccines; C089161:glikopin; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C063429:glucosaminylmuramyl-2-alanine-D-isoglutamine
Printsipy korrektsii vtorichnykh immunodefitsitov dvumia razlichnymi po svoeĭ prirode immunomoduliatorov--anatoksinom stafilokokkovym ochishchennym i likopidom.